Although clinical studies have shown conflicting results concerning the role of GM‐CSF in IBD, diminished levels of GM‐CSF were shown to be associated with increased severity of Crohn's disease and higher susceptibility to acute DSS‐induced colitis in experimental mouse models.[92, 114, 115]. Here, CSF2 is linked to inflammatory bowel disease.